Literature DB >> 8428785

Altered blood pressure during sleep in normotensive subjects with type I diabetes.

A Lurbe1, J Redón, J M Pascual, J Tacons, V Alvarez, D C Batlle.   

Abstract

This study was designed to examine the circadian pattern of blood pressure in children and young adults with type I diabetes who were completely normotensive by standard criteria. Forty-five patients and the same number of age- and sex-matched control subjects were studied. In diabetic children of 10-14 years of age, the nocturnal fall in systolic and diastolic blood pressures was intact. In diabetics of 15-20 years of age, the fall in systolic blood pressure was blunted; in diabetics of 21-37 years of age, the fall in both systolic and diastolic blood pressures during sleep was blunted. When data from all diabetic subjects were pooled and analyzed in a multiple linear regression model, mean blood pressure during sleep correlated best with urinary albumin excretion (r = 0.60). On the basis of this finding, we subdivided our patients into two groups: a microalbuminuric group (urinary albumin excretion > 30 mg per 24 hours; mean, 160.3 +/- 29.7; n = 11) and a normoalbuminuric group (urinary albumin excretion < 30 mg per 24 hours; mean, 6.6 +/- 6.5; n = 34). Both systolic and diastolic blood pressures during sleep were higher in microalbuminuric (121.1 +/- 3.3 and 69.3 +/- 2.5 mm Hg, respectively) than in normoalbuminuric diabetics (114.2 +/- 1.8 and 60.1 +/- 1.2 mm Hg, p < 0.05) or control subjects (113.3 +/- 1.2 and 60.1 +/- 1.2 mm Hg, p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8428785     DOI: 10.1161/01.hyp.21.2.227

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  23 in total

Review 1.  Diagnosis of high blood pressure in children by means of ambulatory blood pressure monitoring.

Authors:  E Lurbe; J Redon
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 3.  Circadian rhythm of blood pressure in renal disease.

Authors:  M Schömig; V Schwenger; E Ritz
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

4.  Twenty-four hour ambulatory blood pressure monitoring in adolescents with type 1 diabetes: getting started.

Authors:  Margaret Pellizzari; Phyllis W Speiser; Dennis E Carey; Pavel Fort; Paula M Kreitzer; Graeme R Frank
Journal:  J Diabetes Sci Technol       Date:  2008-11

Review 5.  Treatment of patients with essential hypertension and microalbuminuria.

Authors:  J Redon
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 6.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

Review 7.  Ambulatory blood pressure monitoring in children and adolescents: coming of age?

Authors:  Empar Lurbe; María Isabel Torró; Julio Alvarez
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 8.  Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.

Authors:  Donn Hogan; Empar Lurbe; M Reza Salabat; Josep Redon; Daniel Batlle
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

9.  Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes.

Authors:  João S Felício; Ana Carolina C B de Souza; Nárcia Kohlmann; Oswaldo Kohlmann; Arthur B Ribeiro; Maria T Zanella
Journal:  Cardiovasc Diabetol       Date:  2010-08-13       Impact factor: 9.951

Review 10.  Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease?

Authors:  K M Moorthi; Donn Hogan; Empar Lurbe; Josep Redon; Daniel Batlle
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.